SCS Hf 10 Burst denied as non-formulary by Aetna?
Non-formulary doesn't mean uncoverable. Most plans have a formulary-exception process: the appeal needs to show the formulary alternatives are inappropriate for your specific clinical situation.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Aetna typically requires
Aetna's specific coverage criteria for scs hf10 burst are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Aetna angle on SCS Hf 10 Burst
## Why Aetna Denies HF10/Burst SCS as Non-Formulary
For durable medical equipment and implantable devices, a "non-formulary" or "non-covered device" denial from Aetna typically means that Aetna's medical policy does not include HF10 or burst SCS under its covered benefit for spinal cord stimulation — either because Aetna's policy specifies only conventional (tonic) SCS parameters, the specific device model is not on Aetna's approved device list, or the policy language has not been updated to reflect distinct coverage for HF10 or burst waveform technology. This is distinct from a general SCS denial: Aetna may cover SCS broadly but restrict coverage to specific device types or stimulation modalities.
## Why This Denial Is Appealable
If the HF10 or burst SCS device is FDA-cleared for the patient's indication and the treating physician has determined it is the medically appropriate choice for this patient, the non-formulary or non-covered-device denial is challengeable. Aetna's device coverage policies must reflect clinical evidence, and plan members retain the right to appeal coverage decisions and seek external review. The appeal must address both the device-level coverage question and the individual patient's clinical need.
## Federal Appeal Framework
- Internal appeal: File within your plan's deadline. Address the coverage classification directly — provide FDA clearance for the specific device and clinical literature supporting the modality.
- Coverage exception request: Some Aetna plans allow a formal coverage exception process for non-covered items when medical necessity is demonstrated. Inquire whether this pathway is available in addition to the standard appeal.
- External review (ACA §2719 / ERISA §503): If internal appeal is denied, request IRO review within 4 months. The IRO evaluates whether the non-formulary determination is consistent with accepted clinical standards and the patient's documented needs.
- State insurance department: If the IRO process is unavailable (e.g., certain self-funded ERISA plans), contact your state insurance commissioner for additional options.
## Documentation to Gather
1. FDA clearance for the specific device — documentation showing that the HF10 or burst SCS device requested is FDA-cleared for the patient's condition. 2. Medical policy comparison — identify the exact language in Aetna's policy that excludes or limits HF10/burst coverage, and address it specifically in the appeal. 3. Clinical distinction rationale — a prescriber letter explaining why HF10 or burst SCS — rather than a conventional SCS device that may be covered — is the medically appropriate choice for this patient (e.g., prior conventional SCS failure, clinical characteristics favoring this modality). 4. Diagnosis and conservative treatment history — full documentation that the patient meets Aetna's underlying SCS coverage criteria, independent of the device-type question. 5. Specialty society guideline references — citations from the applicable pain medicine or neuromodulation society acknowledging HF10/burst SCS as a recognized treatment option.
## Criteria-Mapping Strategy
Obtain Aetna's current published medical policy for spinal cord stimulation. Identify whether the exclusion is device-specific, modality-specific, or indication-specific. Structure the appeal to address the exact basis of exclusion, provide FDA and clinical support for the requested device, and demonstrate that the individual patient's clinical circumstances support coverage under the general SCS policy even if HF10/burst is not explicitly listed.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →